Insomnia Market Research
Insomnia is a sleeping disorder that is characterized by great difficulty in falling asleep. This sleep disorder first made its appearance in Western countries like US and UK, but today, it is also prevalent among Asian populations. The US has the largest number of insomniacs anywhere in the world, followed by Germany and the UK.
In the global arena, the market for insomnia drugs is flourishing. The global insomnia market was valued at approximately $2.75 billion in 2009. It is forecast to reach a value of $2.12 billion by 2017. Further in 2019, the market value for insomnia drugs is forecast to reach $3.5 billion. While growth of the US market is set to be subdued by further generic erosion from 2011 onwards, Japan is likely to represent key growth over the next 10 years.
The Insomnia drug therapy market research report provides insight into the pipeline status of insomnia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the insomnia drugs market.